KALA BIO, Inc. — Form D

KALA BIO, Inc. of ARLINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2012-03-14. The offering totals $7.2M, of which $7.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (44)

Showing 25 of 44 people.

NameRoleLocation
Justin HanesDirectorRedwood City, CA
PETER COUROSSIExecutive OfficerChicago, IL
Robert PaullExecutive OfficerBoston, MA
Kevin PojasekExecutive OfficerWaltham, MA
Robert LangerDirectorPittsburgh, PA
Kevin BittermanDirectorCambridge, MA
Andrew L KovenDirectorCambridge, MA
David LazarDirectorARLINGTON, MA
Darius KharabiExecutive OfficerArlington, MA
Todd BazemoreExecutive OfficerFRAMINGHAM, MA
Gregory D PerryDirectorArlington, MA
Marjan D FaridDirectorArlington, MA
Mark IwickiDirectorArlington, MA
Mark IwickiExecutive OfficerArlington, MA
Mary ReumuthExecutive OfficerArlington, MA
C. Daniel MyersDirectorArlington, MA
Kim BrazzellExecutive OfficerArlington, MA
Brendan PurdyDirectorArlington, MA
Mark S BlumenkranzDirectorArlington, MA
Howard B RosenDirectorSan Mateo, CA
Robert TepperDirectorCambridge, MA
Greg GrunbergDirectorLawrence, MA
Darius Daniel KharabiExecutive OfficerWatertown, MA
Gregory D GrunbergDirectorWatertown, MA
Hongming ChenExecutive OfficerWatertown, MA

Other filings by this issuer (11)

FiledFormOfferingSold
2026-03-17D$1.8M$1.8M
2026-02-13D$4.2M$2.3M
2024-12-31D$10.7M$10.7M
2024-06-28D$12.5M$12.5M
2021-11-29D$36.5M$16.1M
2016-04-13D$67.9M$67.9M
2015-08-19D$7.0M$7.0M
2014-04-24D$22.5M$22.5M
2013-02-28D$11.5M$5.8M
2010-11-10D$3.0M$3.0M
2009-12-23D$2.0M$2.0M

More